Search results for the GEO ID: GSE7579
(Click on the check boxes provided under "Select for analysis", to initiate grouping)
(Once the selection is made, click on "Add groups" in "Make groups for comparison", to make a group. Scroll down)
GSM ID
GPL ID
Select for analysis
Title
Source name
Description
Characteristics
GSM179757
GPL8300
Erythroid progenitor cells. SCF+Epo cells 0hr 1. Cord blood derived erythroid progenitors cultured in SCF+Epo. Human umbilical cord blood was collected according to institutional guidelines after full term pregnancies. Mononuclear cells (MNC) were recovered by Ficoll-Hypaque gradient centrifugation and MNC (2-3 million cells/ml) were cultured with SCF, Epo and dexamethasone (SCF/Epo cells). Drug treatment of human red blood precursor cells. Human red blood precursor cells (SCF/Epo cells), differentiated SCF/Epo cells and differentiated SCF/Epo cells in the presence of thyroid hormone (T3/T4), 9-cis retinoic acid (9cRA) or T3 plus 9cRA.
GSM180044
GPL8300
Erythroid progenitor cells. SCF+Epo cells 0hr 2. Cord blood derived erythroid progenitors cultured in SCF+Epo Human umbilical cord blood was collected according to institutional guidelines after full term pregnancies. Mononuclear cells (MNC) were recovered by Ficoll-Hypaque gradient centrifugation and MNC (2-3 million cells/ml) were cultured with SCF, Epo and dexamethasone (SCF/Epo cells) Drug treatment of human red blood precursor cells. Human red blood precursor cells (SCF/Epo cells), differentiated SCF/Epo cells and differentiated SCF/Epo cells in the presence of thyroid hormone (T3/T4), 9-cis retinoic acid (9cRA) or T3 plus 9cRA.
GSM180045
GPL8300
Erythroid progenitor cells. Epo+insulin cells 8hr 1. Cord blood derived erythroid progenitors. differentiation for 8hrs in Epo+insulin Human umbilical cord blood was collected according to institutional guidelines after full term pregnancies. Mononuclear cells (MNC) were recovered by Ficoll-Hypaque gradient centrifugation and MNC (2-3 million cells/ml) were cultured with SCF, Epo and dexamethasone (SCF/Epo cells) and differentiated into red blood cells with Epo and insulin (Epo/insulin cells) for 8 hrs. Drug treatment of human red blood precursor cells. Human red blood precursor cells (SCF/Epo cells), differentiated SCF/Epo cells and differentiated SCF/Epo cells in the presence of thyroid hormone (T3/T4), 9-cis retinoic acid (9cRA) or T3 plus 9cRA.
GSM180046
GPL8300
Erythroid progenitor cells. Epo+insulin cells 8hr 2. Cord blood derived erythroid progenitors. differentiation for 8hrs in Epo+insulin Human umbilical cord blood was collected according to institutional guidelines after full term pregnancies. Mononuclear cells (MNC) were recovered by Ficoll-Hypaque gradient centrifugation and MNC (2-3 million cells/ml) were cultured with SCF, Epo and dexamethasone (SCF/Epo cells) and differentiated into red blood cells with Epo and insulin (Epo/insulin cells) for 8 hrs. Drug treatment of human red blood precursor cells. Human red blood precursor cells (SCF/Epo cells), differentiated SCF/Epo cells and differentiated SCF/Epo cells in the presence of thyroid hormone (T3/T4), 9-cis retinoic acid (9cRA) or T3 plus 9cRA.
GSM180047
GPL8300
Erythroid progenitor cells. Epo+insulin cells 24hr 1. Cord blood derived erythroid progenitors. differentiation for 24 hrs in Epo+insulin Human umbilical cord blood was collected according to institutional guidelines after full term pregnancies. Mononuclear cells (MNC) were recovered by Ficoll-Hypaque gradient centrifugation and MNC (2-3 million cells/ml) were cultured with SCF, Epo and dexamethasone (SCF/Epo cells) and differentiated into red blood cells with Epo and insulin (Epo/insulin cells) for 24 hrs. Drug treatment of human red blood precursor cells. Human red blood precursor cells (SCF/Epo cells), differentiated SCF/Epo cells and differentiated SCF/Epo cells in the presence of thyroid hormone (T3/T4), 9-cis retinoic acid (9cRA) or T3 plus 9cRA.
GSM180048
GPL8300
Erythroid progenitor cells. Epo+insulin cells 24hr 2. Cord blood derived erythroid progenitors. differentiation for 24 hrs in Epo+insulin Human umbilical cord blood was collected according to institutional guidelines after full term pregnancies. Mononuclear cells (MNC) were recovered by Ficoll-Hypaque gradient centrifugation and MNC (2-3 million cells/ml) were cultured with SCF, Epo and dexamethasone (SCF/Epo cells) and differentiated into red blood cells with Epo and insulin (Epo/insulin cells) for 24 hrs Drug treatment of human red blood precursor cells. Human red blood precursor cells (SCF/Epo cells), differentiated SCF/Epo cells and differentiated SCF/Epo cells in the presence of thyroid hormone (T3/T4), 9-cis retinoic acid (9cRA) or T3 plus 9cRA.
GSM180049
GPL8300
Erythroid progenitor cells. Epo+insulin cells 48hr 1. Cord blood derived erythroid progenitors. differentiation for 48 hrs in Epo+insulin Human umbilical cord blood was collected according to institutional guidelines after full term pregnancies. Mononuclear cells (MNC) were recovered by Ficoll-Hypaque gradient centrifugation and MNC (2-3 million cells/ml) were cultured with SCF, Epo and dexamethasone (SCF/Epo cells) and differentiated into red blood cells with Epo and insulin (Epo/insulin cells) for 48 hrs Drug treatment of human red blood precursor cells. Human red blood precursor cells (SCF/Epo cells), differentiated SCF/Epo cells and differentiated SCF/Epo cells in the presence of thyroid hormone (T3/T4), 9-cis retinoic acid (9cRA) or T3 plus 9cRA.
GSM180050
GPL8300
Erythroid progenitor cells. Epo+insulin cells 48hr 2. Cord blood derived erythroid progenitors. differentiation for 48 hrs in Epo+insulin Human umbilical cord blood was collected according to institutional guidelines after full term pregnancies. Mononuclear cells (MNC) were recovered by Ficoll-Hypaque gradient centrifugation and MNC (2-3 million cells/ml) were cultured with SCF, Epo and dexamethasone (SCF/Epo cells) and differentiated into red blood cells with Epo and insulin (Epo/insulin cells) for 48 hrs Drug treatment of human red blood precursor cells. Human red blood precursor cells (SCF/Epo cells), differentiated SCF/Epo cells and differentiated SCF/Epo cells in the presence of thyroid hormone (T3/T4), 9-cis retinoic acid (9cRA) or T3 plus 9cRA.
GSM180051
GPL8300
Erythroid progenitor cells. Epo+insulin cells 8hr +T3 +9cRA 2. Cord blood derived erythroid progenitors. differentiation for 8hrs in Epo+insulin +T3 +9cRA Human umbilical cord blood was collected according to institutional guidelines after full term pregnancies. Mononuclear cells (MNC) were recovered by Ficoll-Hypaque gradient centrifugation and MNC (2-3 million cells/ml) were cultured with SCF, Epo and dexamethasone (SCF/Epo cells) and differentiated into red blood cells with Epo and insulin (Epo/insulin cells) and T3, 9cRA or T3+9cRA Drug treatment of human red blood precursor cells. Human red blood precursor cells (SCF/Epo cells), differentiated SCF/Epo cells and differentiated SCF/Epo cells in the presence of thyroid hormone (T3/T4), 9-cis retinoic acid (9cRA) or T3 plus 9cRA.
GSM180052
GPL8300
Erythroid progenitor cells. Epo+insulin cells 24hr +T3 +9cRA 2. Cord blood derived erythroid progenitors. differentiation for 24hrs in Epo+insulin +T3 +9cRA Human umbilical cord blood was collected according to institutional guidelines after full term pregnancies. Mononuclear cells (MNC) were recovered by Ficoll-Hypaque gradient centrifugation and MNC (2-3 million cells/ml) were cultured with SCF, Epo and dexamethasone (SCF/Epo cells) and differentiated into red blood cells with Epo and insulin (Epo/insulin cells) and T3, 9cRA or T3+9cRA for 24 hrs. Drug treatment of human red blood precursor cells. Human red blood precursor cells (SCF/Epo cells), differentiated SCF/Epo cells and differentiated SCF/Epo cells in the presence of thyroid hormone (T3/T4), 9-cis retinoic acid (9cRA) or T3 plus 9cRA.
GSM180053
GPL8300
Erythroid progenitor cells. Epo+insulin cells 48hr +T3 +9cRA 2. Cord blood derived erythroid progenitors. differentiation for 48hrs in Epo+insulin +T3 +9cRA Human umbilical cord blood was collected according to institutional guidelines after full term pregnancies. Mononuclear cells (MNC) were recovered by Ficoll-Hypaque gradient centrifugation and MNC (2-3 million cells/ml) were cultured with SCF, Epo and dexamethasone (SCF/Epo cells) and differentiated into red blood cells with Epo and insulin (Epo/insulin cells) and T3, 9cRA or T3+9cRA for 48 hrs. Drug treatment of human red blood precursor cells. Human red blood precursor cells (SCF/Epo cells), differentiated SCF/Epo cells and differentiated SCF/Epo cells in the presence of thyroid hormone (T3/T4), 9-cis retinoic acid (9cRA) or T3 plus 9cRA.
GSM180054
GPL8300
Erythroid progenitor cells. Epo+insulin cells 8hr +9cRA 2. Cord blood derived erythroid progenitors. differentiation for 8hrs in Epo+insulin +9cRA Human umbilical cord blood was collected according to institutional guidelines after full term pregnancies. Mononuclear cells (MNC) were recovered by Ficoll-Hypaque gradient centrifugation and MNC (2-3 million cells/ml) were cultured with SCF, Epo and dexamethasone (SCF/Epo cells) and differentiated into red blood cells with Epo and insulin (Epo/insulin cells) and T3, 9cRA or T3+9cRA for 8 hrs Drug treatment of human red blood precursor cells. Human red blood precursor cells (SCF/Epo cells), differentiated SCF/Epo cells and differentiated SCF/Epo cells in the presence of thyroid hormone (T3/T4), 9-cis retinoic acid (9cRA) or T3 plus 9cRA.
GSM180056
GPL8300
Erythroid progenitor cells. Epo+insulin cells 8hr +T3 2. Cord blood derived erythroid progenitors. differentiation for 8hrs in Epo+insulin +T3 Human umbilical cord blood was collected according to institutional guidelines after full term pregnancies. Mononuclear cells (MNC) were recovered by Ficoll-Hypaque gradient centrifugation and MNC (2-3 million cells/ml) were cultured with SCF, Epo and dexamethasone (SCF/Epo cells) and differentiated into red blood cells with Epo and insulin (Epo/insulin cells) and T3, 9cRA or T3+9cRA for 8 hrs Drug treatment of human red blood precursor cells. Human red blood precursor cells (SCF/Epo cells), differentiated SCF/Epo cells and differentiated SCF/Epo cells in the presence of thyroid hormone (T3/T4), 9-cis retinoic acid (9cRA) or T3 plus 9cRA.
 
 
Make groups for comparisons
(2 groups will be compared at a time)
Select GSMs and click on "Add groups"
Enter the group name here:


Select expression type
Transcripts profile based on;
A. Differential status (Up/Down regulation)
B. Absolute calls (Transcribed/Not-detected)
 
Filter results by number of probes